Exhibit 107
EX-FILING FEES
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Organicell Regenerative Medicine, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit(2) | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, $0.001 par value | 457(c) | 100,000,000 | $ | 0.04 | $ | 4,000,000 | $ | 0.0001102 | $ | 440.80 | ||||||||||||||||
| Fees Previously Paid | $ | 185.40 | ||||||||||||||||||||||||||
| Total Offering Amounts | $ |
| ||||||||||||||||||||||||||
| Total Fee Offsets | 185.40 | |||||||||||||||||||||||||||
| Net Fee Due | $ | 255.40 | ||||||||||||||||||||||||||
| (1) | We are registering 100,000,000 shares of our common stock that we will put to Tysadco Partners, LLC, a Delaware limited liability company, pursuant to that certain purchase agreement dated September 1, 2022 (the “Purchase Agreement”). Additionally, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock offered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions that could affect the shares to be offered by the selling stockholder. In the event that the adjustment provisions of the Purchase Agreement require the registrant to issue more shares than are being registered in this registration statement, for reasons other than those stated in Rule 416 of the Securities Act, the registrant will file a new registration statement to register those additional securities. |
| (2) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act, based on the average of the high and low prices of the common stock of the registrant on the OTCQB tier of the over-the-counter market as reported by OTC Markets Group, Inc. on October 19, 2022. |
